AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Cocker, HA Tiffin, N Pritchard-Jones, K Pinkerton, CR Kelland, LR
Citation: Ha. Cocker et al., In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line, CLIN CANC R, 7(10), 2001, pp. 3193-3198

Authors: Rapley, EA Hargrave, D Persinguhe, N Barfoot, R Moore, I Radford, M Stratton, MR Rahman, N Pritchard-Jones, K
Citation: Ea. Rapley et al., Case of interstitial 12q deletion in association with Wilms tumor, AM J MED G, 104(3), 2001, pp. 246-249

Authors: Gordon, T McManus, A Anderson, J Min, T Swansbury, J Pritchard-Jones, K Shipley, J
Citation: T. Gordon et al., Cytogenetic abnormalities in 42 rhabdomyosarcoma: A United Kingdom Cancer Cytogenetics Group Study, MED PED ONC, 36(2), 2001, pp. 259-267

Authors: Lu, YJ Williamson, D Clark, J Wang, R Tiffin, N Skelton, L Gordon, T Williams, R Allan, B Jackman, A Cooper, C Pritchard-Jones, K Shipley, J
Citation: Yj. Lu et al., Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression, P NAS US, 98(16), 2001, pp. 9197-9202

Authors: Grundy, R Anderson, J Gaze, M Gerrard, M Glaser, A Gordon, A Malone, M Pritchard-Jones, K Michalski, A
Citation: R. Grundy et al., Congenital alveolar rhabdomyosarcoma - Clinical and molecular distinction from alveolar rhabdomyosarcoma in older children, CANCER, 91(3), 2001, pp. 606-612

Authors: Anderson, J Gordon, T McManus, A Mapp, T Gould, S Kelsey, A McDowell, H Pinkerton, R Shipley, J Pritchard-Jones, K
Citation: J. Anderson et al., Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?, BR J CANC, 85(6), 2001, pp. 831-835

Authors: Anderson, J Ramsay, A Gould, S Pritchard-Jones, K
Citation: J. Anderson et al., PAX3-FKHR induces morphological change and enhances cellular proliferationand invasion in rhabdomyosarcoma, AM J PATH, 159(3), 2001, pp. 1089-1096

Authors: Hing, S Lu, YJ Summersgill, B King-Underwood, L Nicholson, J Grundy, P Grundy, R Gessler, M Shipley, J Pritchard-Jones, K
Citation: S. Hing et al., Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors, AM J PATH, 158(2), 2001, pp. 393-398

Authors: Rahman, N Arbour, L Houlston, R Bonaiti-Pellie, C Abidi, F Tranchemontagne, J Ford, D Narod, S Pritchard-Jones, K Foulkes, WD Schwartz, C Stratton, MR
Citation: N. Rahman et al., Penetrance of mutations in the familial Wilms tumor gene FWT1, J NAT CANC, 92(8), 2000, pp. 650-652

Authors: Gordon, AT Brinkschmidt, C Anderson, J Coleman, N Dockhorn-Dworniczak, B Pritchard-Jones, K Shipley, J
Citation: At. Gordon et al., A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma, GENE CHROM, 28(2), 2000, pp. 220-226

Authors: Coppes, MJ Pritchard-Jones, K
Citation: Mj. Coppes et K. Pritchard-jones, Principles of Wilms' tumor biology, UROL CLIN N, 27(3), 2000, pp. 423

Authors: Pritchard-Jones, K Rahman, N Gerrard, M Variend, D King-Underwood, L
Citation: K. Pritchard-jones et al., Familial Wilms tumour resulting from WT1 mutation: intronic polymorphism causing artefactual constitutional homozygosity, J MED GENET, 37(5), 2000, pp. 377-379

Authors: Rapley, EA Barfoot, R Bonaiti-Pellie, C Chompret, A Foulkes, W Perusinghe, N Reeve, A Royer-Pokora, B Schumacher, V Shelling, A Skeen, J de Tourreil, S Weirich, A Pritchard-Jones, K Stratton, MR Rahman, N
Citation: Ea. Rapley et al., Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2, BR J CANC, 83(2), 2000, pp. 177-183

Authors: Pritchard-Jones, K
Citation: K. Pritchard-jones, Distinguished Career Award of the American Society of Pediatric Hematology/Oncology for 1999 - Alfred G. Knudson, J PED H ONC, 21(4), 1999, pp. 258-258

Authors: Anderson, J Gordon, A Pritchard-Jones, K Shipley, J
Citation: J. Anderson et al., Genes, chromosomes, and rhabdomyosarcoma, GENE CHROM, 26(4), 1999, pp. 275-285

Authors: Pritchard-Jones, K
Citation: K. Pritchard-jones, The Wilms tumour gene, WT1, in normal and abnormal nephrogenesis, PED NEPHROL, 13(7), 1999, pp. 620-625

Authors: Yanagisawa, T Newman, A Coley, H Renshaw, J Pinkerton, CR Pritchard-Jones, K
Citation: T. Yanagisawa et al., BIRICODAR (VX-710; Incel (TM)): an effective chemosensitizer in neuroblastoma, BR J CANC, 80(8), 1999, pp. 1190-1196

Authors: Rahman, N Abidi, F Ford, D Arbour, L Rapley, E Tonin, P Barton, D Batcup, G Berry, J Cotter, F Davison, V Gerrard, M Gray, E Grundy, R Hanafy, M King, D Lewis, I Luethy, AR Madlensky, L Mann, J O'Meara, A Oakhill, T Skolnick, M Strong, L Variend, D Narod, S Schwartz, C Pritchard-Jones, K Stratton, MR
Citation: N. Rahman et al., Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypiccharacteristics of Wilms' tumour attributable to FWT1, HUM GENET, 103(5), 1998, pp. 547-556
Risultati: 1-18 |